{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:29:09Z","timestamp":1769282949083,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T00:00:00Z","timestamp":1236124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11064-009-9929-4","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T05:59:06Z","timestamp":1236059946000},"page":"1427-1432","source":"Crossref","is-referenced-by-count":19,"title":["Altered Platelet Monoamine Oxidase-B Activity in Idiopathic Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Maroof","family":"Husain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep K.","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika","family":"Nag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikhab C.","family":"Srimal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prahlad K.","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,4]]},"reference":[{"key":"9929_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000110376","volume":"13","author":"S Moghal","year":"1994","unstructured":"Moghal S, Rajput AH, D\u2019 Arey C, Rajput R (1994) Prevalence of movement disorders in elderly community residents. Neuroepidemiology 13:175\u2013178. doi: 10.1159\/000110376","journal-title":"Neuroepidemiology"},{"key":"9929_CR2","first-page":"51","volume-title":"Parkinson\u2019s disease","author":"MH Ratner","year":"2005","unstructured":"Ratner MH, Feldman RG (2005) Environmental toxins and Parkinson\u2019s disease. In: Ebadi M, Pfeiffer RF (eds) Parkinson\u2019s disease. CRC Press, Florida, pp 51\u201362"},{"key":"9929_CR3","first-page":"352","volume":"60","author":"EP Bharucha","year":"1993","unstructured":"Bharucha EP, Bharucha NE (1993) Epidemiological study of Parkinson\u2019s disease in Parsis in India. Adv Neurol 60:352\u2013354","journal-title":"Adv Neurol"},{"key":"9929_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mds.870100503","volume":"10","author":"E Tandberg","year":"1995","unstructured":"Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA (1995) The epidemiology of Parkinson\u2019s disease in the country of Rogaland Norway. Mov Disord 10:541\u2013549. doi: 10.1002\/mds.870100503","journal-title":"Mov Disord"},{"key":"9929_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-0404.1995.tb00478.x","volume":"92","author":"RL Sutcliffe","year":"1995","unstructured":"Sutcliffe RL, Meara JR (1995) Parkinson\u2019s disease epidemiology in the Northampton district, England, 1992. Acta Neurol Scand 92:443\u2013450","journal-title":"Acta Neurol Scand"},{"key":"9929_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000110318","volume":"12","author":"ZX Zhang","year":"1993","unstructured":"Zhang ZX, Roman GC (1993) Worldwide occurrence of Parkinson\u2019s disease: an updated review. Neuroepidemiology 12:195\u2013208. doi: 10.1159\/000110318","journal-title":"Neuroepidemiology"},{"key":"9929_CR7","first-page":"39","volume-title":"Parkinson\u2019s disease","author":"M Korell","year":"2005","unstructured":"Korell M, Tanner CM (2005) Epidemiology of Parkinson\u2019s disease: an overview. In: Ebadi M, Pfeiffer RF (eds) Parkinson\u2019s disease. CRC Press, Florida, pp 39\u201350"},{"key":"9929_CR8","first-page":"27","volume-title":"Parkinson\u2019s disease","author":"A Kumar","year":"2005","unstructured":"Kumar A, Huang Z, Calne DB (2005) Parkinson\u2019s disease: where are we? In: Ebadi M, Pfeiffer RF (eds) Parkinson\u2019s disease. CRC Press, Florida, pp 27\u201338"},{"issue":"3","key":"9929_CR9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.48.3.650","volume":"48","author":"JM Gorell","year":"1997","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Grown GG (1997) Occupational exposures to metals as risk factors for Parkinson\u2019s disease. Neurology 48(3):650\u2013658","journal-title":"Neurology"},{"issue":"5","key":"9929_CR10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living. Neurology 50(5):1346\u20131350","journal-title":"Neurology"},{"key":"9929_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1353-8020(01)00054-2","volume":"8","author":"BCL Lai","year":"2002","unstructured":"Lai BCL, Marion SA, Teschke K, Tsui JKC (2002) Occupational and environmental risk factors for Parkinson\u2019s disease. Parkinsonism Relat Disord 8:297\u2013309. doi: 10.1016\/S1353-8020(01)00054-2","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"9929_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0404.2002.1o040.x","volume":"105","author":"M Zorzon","year":"2002","unstructured":"Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R (2002) Familial and environmental risk factors in Parkinson\u2019s disease: a case-control study in north-east Italy. Acta Neurol Scand 105(2):77\u201382. doi: 10.1034\/j.1600-0404.2002.1o040.x","journal-title":"Acta Neurol Scand"},{"issue":"9137","key":"9929_CR13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(98)03453-9","volume":"352","author":"A Menegon","year":"1998","unstructured":"Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteukr DG (1998) Parkinson\u2019s disease, pesticides and glutathione transferase polymorphisms. Lancet 352(9137):1344\u20131346. doi: 10.1016\/S0140-6736(98)03453-9","journal-title":"Lancet"},{"issue":"8","key":"9929_CR14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/oxfordjournals.aje.a117497","volume":"141","author":"KM Semchuk","year":"1995","unstructured":"Semchuk KM, Love EJ (1995) Effects of agricultural work and other proxy-derived case-control data on Parkinson\u2019s disease risk estimates. Am J Epidemiol 141(8):747\u2013754","journal-title":"Am J Epidemiol"},{"issue":"4","key":"9929_CR15","first-page":"435","volume":"21","author":"A Priyadarshi","year":"2000","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S (2000) A meta-analysis of Parkinson\u2019s disease and exposure to pesticides. Neurotoxicology 21(4):435\u2013440","journal-title":"Neurotoxicology"},{"issue":"12","key":"9929_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, Mac Kenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306. doi: 10.1038\/81834","journal-title":"Nat Neurosci"},{"key":"9929_CR17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"AE Lange","year":"1998","unstructured":"Lange AE, Lozano AM (1998) Parkinson\u2019s disease: first of two parts. N Engl J Med 339:1044\u20131053. doi: 10.1056\/NEJM199810083391506","journal-title":"N Engl J Med"},{"key":"9929_CR18","volume-title":"Reactive oxygen species in biological systems","author":"G Cohen","year":"1999","unstructured":"Cohen G (1999) Oxidative stress and Parkinson\u2019s disease. In: Gilbert DC, Colton CA (eds) Reactive oxygen species in biological systems. Kluwer Academic\/Plenum Publishers, New York"},{"key":"9929_CR19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689\u2013694. doi: 10.1126\/science.7901908","journal-title":"Science"},{"key":"9929_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0166-2236(93)90070-3","volume":"16","author":"CW Olanow","year":"1993","unstructured":"Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439\u2013444. doi: 10.1016\/0166-2236(93)90070-3","journal-title":"Trends Neurosci"},{"issue":"6, Suppl 3","key":"9929_CR21","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","volume":"47","author":"P Jenner","year":"1996","unstructured":"Jenner P, Olanow CW (1996) Oxidative stress and pathogenesis of Parkinson\u2019s disease. Neurology 47(6, Suppl 3):S161\u2013S170","journal-title":"Neurology"},{"key":"9929_CR22","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR (2004) Parkinson\u2019s disease. Lancet 363:1783\u20131793. doi: 10.1016\/S0140-6736(04)16305-8","journal-title":"Lancet"},{"key":"9929_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci 28:57\u201387. doi: 10.1146\/annurev.neuro.28.061604.135718","journal-title":"Annu Rev Neurosci"},{"key":"9929_CR24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0014-2999(90)93436-T","volume":"183","author":"VK Khanna","year":"1990","unstructured":"Khanna VK, Maheshwari PK, Nag D, Seth PK (1990) Usefulness of platelet neurotransmitter receptors in Parkinson\u2019s disease. Eur J Pharmacol 183:531\u2013532. doi: 10.1016\/0014-2999(90)93436-T","journal-title":"Eur J Pharmacol"},{"key":"9929_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0163-7258(90)90064-9","volume":"47","author":"W Weyler","year":"1990","unstructured":"Weyler W, Hsu YP, Breakfield XO (1990) Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47:391\u2013417. doi: 10.1016\/0163-7258(90)90064-9","journal-title":"Pharmacol Ther"},{"key":"9929_CR26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jnr.490160403","volume":"16","author":"LM Kochersperger","year":"1986","unstructured":"Kochersperger LM, Parker EL, Siciano M, Darlington GJ, Denly RM (1986) Assignment of genes for human monoamine oxidase A and B to the X chromosomes. J Neurosci Res 16:601\u2013616. doi: 10.1002\/jnr.490160403","journal-title":"J Neurosci Res"},{"key":"9929_CR27","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","volume":"29","author":"JJ Chen","year":"2007","unstructured":"Chen JJ, Swope DM, Dashtipour K (2007) Comprehensive review of rasagiline, a second generation monoamine oxidase inhibitor, for the treatment of Parkinson\u2019s disease. Clin Ther 29:1825\u20131846. doi: 10.1016\/j.clinthera.2007.09.021","journal-title":"Clin Ther"},{"key":"9929_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-1781(93)90092-U","volume":"46","author":"NL Pedersen","year":"1993","unstructured":"Pedersen NL, Oreland L, Reynolds C, McClearn GE (1993) Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together. Psychiatry Res 46:239\u2013251. doi: 10.1016\/0165-1781(93)90092-U","journal-title":"Psychiatry Res"},{"key":"9929_CR29","first-page":"36","volume":"36","author":"J Rice","year":"1984","unstructured":"Rice J, McGuffin P, Goldin LR, Shaskan EG, Gershon ES (1984) Platelet monoamine oxidase (MAO) activity: evidence for a single major locus. Am J Hum Genet 36:36\u201343","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9929_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1531-8257(199903)14:2<219::AID-MDS1003>3.0.CO;2-9","volume":"14","author":"GD Mellick","year":"1999","unstructured":"Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou N, Chan D, Le Couteur DG (1999) Variations in the monoamine oxidase B (MAO B) gene are associated with Parkinson\u2019s disease. Mov Disord 14(2):219\u2013224. doi: 10.1002\/1531-8257(199903)14:2<219::AID-MDS1003>3.0.CO;2-9","journal-title":"Mov Disord"},{"key":"9929_CR31","first-page":"127","volume-title":"Monoamine oxidase and Parkinson\u2019s disease","author":"H Kinemuchi","year":"1993","unstructured":"Kinemuchi H, Arai Y, Fowler CJ (1993) A role for monoamineoxidase in the development of Parkinson\u2019s disease. In: Yasuhara H (ed) Monoamine oxidase and Parkinson\u2019s disease. Academic Press, London, pp 127\u2013135"},{"key":"9929_CR32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0140-6736(90)90063-B","volume":"20","author":"G Steventon","year":"1990","unstructured":"Steventon G, Humfrey C, Sturman S, Waring RH, Williams AC (1990) Monoamine oxidase-B and Parkinson\u2019s disease. Lancet 20:180. doi: 10.1016\/0140-6736(90)90063-B","journal-title":"Lancet"},{"key":"9929_CR33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/neur.1996.0047","volume":"5","author":"P Bongioanni","year":"1996","unstructured":"Bongioanni P, Mondino C, Boccardi B, Borgna M (1996) Monoamine molecular activity in platelets of parkinsonian and demented patients. Neurodegeneration 5:351\u2013357. doi: 10.1006\/neur.1996.0047","journal-title":"Neurodegeneration"},{"key":"9929_CR34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.53.10.854","volume":"53","author":"U Bonuccelli","year":"1990","unstructured":"Bonuccelli U, Piccini P, Del Dotto P, Pacifici GM, Corsini GU, Muratorio A (1990) Platelet monoamine oxidase B activity in Parkinsonian patients. J Neurol Neurosurg Psychiatry 53:854\u2013855. doi: 10.1136\/jnnp.53.10.854","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9929_CR35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1600-0447.1988.tb06412.x","volume":"78","author":"W Danielczyk","year":"1988","unstructured":"Danielczyk W, Streifler M, Konradic C, Reiderer P, Moll G (1988) Platelet MAO-B activity and the psychopathology of Parkinson\u2019s disease, seniile dementia and multi-infarct dementia. Acta Psychiatr Scand 78:730\u2013736. doi: 10.1111\/j.1600-0447.1988.tb06412.x","journal-title":"Acta Psychiatr Scand"},{"key":"9929_CR36","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/0006-2952(90)90101-P","volume":"41","author":"C Humfrey","year":"1990","unstructured":"Humfrey C, Steventon G, Sturman S, Waring RH, Griffiths B, Williams AC (1990) Monoamine oxidase substrate in Parkinson\u2019s disease. Biochem Pharmacol 41:2562\u20132564. doi: 10.1016\/0006-2952(90)90101-P","journal-title":"Biochem Pharmacol"},{"key":"9929_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0317167100034090","volume":"25","author":"W Kuhn","year":"1998","unstructured":"Kuhn W, Muller T, Gerstner A, Winkel R, Goetz ME (1998) Platelet monoamine oxidase B activity in de novo and L-dopa treated Parkinsonian patients and controls. Can J Neurol Sci 25:249\u2013251","journal-title":"Can J Neurol Sci"},{"key":"9929_CR38","first-page":"635","volume":"19","author":"H Checkoway","year":"1998","unstructured":"Checkoway H, Farin FM, Costa-Mallen P, Kirchner SC, Costa LG (1998) Genetic polymorphism in Parkinson\u2019s disease. Neurotoxicology 19:635\u2013644","journal-title":"Neurotoxicology"},{"key":"9929_CR39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1212\/WNL.58.9.1381","volume":"58","author":"MA Herman","year":"2002","unstructured":"Herman MA, Checkoway H, O\u2019Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A (2002) MAO-B intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58:1381\u20131387","journal-title":"Neurology"},{"key":"9929_CR40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0161-813X(02)00061-X","volume":"23","author":"SN Kelada","year":"2002","unstructured":"Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Pranklin GM, Swanson PD, Longstreth WT, Checkoway H (2002) Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson\u2019s disease. Neurotoxicology 23:515\u2013519. doi: 10.1016\/S0161-813X(02)00061-X","journal-title":"Neurotoxicology"},{"key":"9929_CR41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.b.20035","volume":"120B","author":"EK Tan","year":"2003","unstructured":"Tan EK, Chai Y, Lum SY, Shen H, Tan C, Teoh ML, Yih Y, Wong MC, Zhao Y (2003) Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson\u2019s disease: a study in an Asian population. Am J Med Genet 120B:58\u201362. doi: 10.1002\/ajmg.b.20035","journal-title":"Am J Med Genet"},{"key":"9929_CR42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ygeno.2003.09.002","volume":"83","author":"A Parsian","year":"2004","unstructured":"Parsian A, Racette B, Shang ZH, Rundle M, Perlmutter JS (2004) Association of variations in monoamine oxidase A and B with Parkinson\u2019s disease subgroups. Genomics 83:454\u2013460. doi: 10.1016\/j.ygeno.2003.09.002","journal-title":"Genomics"},{"key":"9929_CR43","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","volume":"32","author":"DB Calne","year":"1992","unstructured":"Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson\u2019s disease. Ann Neurol 32:S125\u2013S127. doi: 10.1002\/ana.410320721","journal-title":"Ann Neurol"},{"key":"9929_CR44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism, onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"9929_CR45","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/0024-3205(88)90127-0","volume":"42","author":"O Suzuki","year":"1988","unstructured":"Suzuki O, Seno H, Kumazawa T (1988) In vitro inhibition of human platelet monoamine oxidase by phenothiazine derivatives. Life Sci 42:2131\u20132136. doi: 10.1016\/0024-3205(88)90127-0","journal-title":"Life Sci"},{"key":"9929_CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9929_CR47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/238225a0","volume":"238","author":"DL Murphy","year":"1972","unstructured":"Murphy DL, Wyatt RJ (1972) Reduced monoamine oxidase activity in blood platelet from schizophrenia patients. Nature 238:225\u2013226. doi: 10.1038\/238225a0","journal-title":"Nature"},{"key":"9929_CR48","first-page":"161","volume":"32","author":"MM Caramona","year":"1990","unstructured":"Caramona MM, Cotrim MD, Ribeiro CF, Macedo T (1990) Monoamine oxidase in blood platelets of migraine patients. J Neural Transm Suppl 32:161\u2013164","journal-title":"J Neural Transm Suppl"},{"key":"9929_CR49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/jnnp.44.9.786","volume":"44","author":"V Glover","year":"1981","unstructured":"Glover V, Peatfield R, Zammit-Pace R, Littlewood J, Gawel M, Rose FC (1981) Platelet monoamine oxidase activity and headache. J Neurol Neurosurg Psychiatry 44:786\u2013790. doi: 10.1136\/jnnp.44.9.786","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9929_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1526-4610.1984.hed2401030.x","volume":"24","author":"J Littlewood","year":"1984","unstructured":"Littlewood J, Glover V, Sandler M, Petty R, Peatfield R, Rose FC (1984) Migraine and cluster headache: links between platelet monoamine oxidase activity, smoking and personality. Headache 24:30\u201334. doi: 10.1111\/j.1526-4610.1984.hed2401030.x","journal-title":"Headache"},{"key":"9929_CR51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.0902-4441.2000.ap90062.x","volume":"101","author":"M Diaz-Marsa","year":"2000","unstructured":"Diaz-Marsa M, Carrasco JL, Hollander E, Cesar J, Saiz-Ruiz J (2000) Decreased platelet monoamine oxidase activity in female anorexia nervosa. Acta Psychiatr Scand 101:226\u2013230. doi: 10.1046\/j.0902-4441.2000.ap90062.x","journal-title":"Acta Psychiatr Scand"},{"key":"9929_CR52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000017026","volume":"9","author":"ME Gotz","year":"1998","unstructured":"Gotz ME, Fischer P, Gsell W, Riederer P, Streifler M, Simanyi M, Muller F, Danielczyk W (1998) Platelet monoamine oxidase-B activity in dementia\u2014a 4\u00a0year follow up. Dement Geriatr Cogn Disord 9:74\u201377. doi: 10.1159\/000017026","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9929_CR53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mds.870120305","volume":"12","author":"N Andreu","year":"1997","unstructured":"Andreu N, Damase-Michel C, Senard JM, Rascol O, Montastru JL (1997) A dose-ranging study of selegiline in patients with Parkinson\u2019s disease: effect on platelet monoamine oxidase activity. Mov Disord 12:293\u2013296. doi: 10.1002\/mds.870120305","journal-title":"Mov Disord"},{"key":"9929_CR54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/jnnp.70.2.229","volume":"70","author":"G Zhou","year":"2001","unstructured":"Zhou G, Miura Y, Shoji H, Yamada S, Matsuishi T (2001) Platelet monoamine oxidase B and plasma beta phenylethylamine in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 70:229\u2013231. doi: 10.1136\/jnnp.70.2.229","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9929_CR55","first-page":"691","volume-title":"Parkinson\u2019s disease","author":"J Bertoni","year":"2005","unstructured":"Bertoni J, Elmer L (2005) The role of MAO-B inhibitors in the treatment of Parkinson\u2019s disease. In: Ebadi M, Pfeiffer RF (eds) Parkinson\u2019s disease. CRC Press, Florida, pp 691\u2013704"},{"issue":"S4","key":"9929_CR56","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/mds.5559","volume":"17","author":"AE Lang","year":"2002","unstructured":"Lang AE, Lees A (2002) MAO-B inhibitors for the treatment of Parkinson\u2019s disease. Mov Disord 17(S4):S38\u2013S44. doi: 10.1002\/mds.5559","journal-title":"Mov Disord"},{"key":"9929_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02260909","volume":"5","author":"J Jarman","year":"1993","unstructured":"Jarman J, Glover V, Sandler M, Turjanski M, Stern G (1993) Platelet monoamine oxidase B activity in Parkinson\u2019s disease: a re-evaluation. J Neural Transm Park Dis Dement Sect 5:1\u20134. doi: 10.1007\/BF02260909","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"9929_CR58","volume-title":"Parkinson\u2019s disease and movement disorders","author":"JJ Jankovic","year":"2002","unstructured":"Jankovic JJ (2002) Therapeutic strategies in Parkinson\u2019s disease. In: Jankovic JJ, Tolosa E (eds) Parkinson\u2019s disease and movement disorders. Lippincott, Philadelphia"},{"key":"9929_CR59","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0022-3565(25)20316-0","volume":"258","author":"LA Peterson","year":"1991","unstructured":"Peterson LA, Juorio AV, Berry MD, Zhu MY (1991) Inhibition of monoamine oxidase-B by (-) deprenyl potentiates neuronal response to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. J Pharmacol Exp Ther 258:1019\u20131024","journal-title":"J Pharmacol Exp Ther"},{"key":"9929_CR60","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1476-5381.1994.tb17119.x","volume":"113","author":"MD Berry","year":"1994","unstructured":"Berry MD, Scarr E, Zhu MY, Peterson LA, Jourio AV (1994) The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurons response to dopamine. Br J Pharmacol 113:1159\u20131166","journal-title":"Br J Pharmacol"},{"key":"9929_CR61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02248668","volume":"1","author":"DH Lee","year":"1989","unstructured":"Lee DH, Mendoza M, Dyorozniak MT, Chung E, Van Woert MH, Yahr MD (1989) Platelet monoamine oxidase in Parkinson patients: effect of l-deprenyl therapy. J Neural Transm 1:189\u2013194. doi: 10.1007\/BF02248668","journal-title":"J Neural Transm"},{"key":"9929_CR62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/379733a0","volume":"379","author":"JS Fowler","year":"1996","unstructured":"Fowler JS, Volkow ND, Wong GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase in the brains of smokers. Nature 379:733\u2013736. doi: 10.1038\/379733a0","journal-title":"Nature"},{"key":"9929_CR63","first-page":"A334","volume":"48","author":"GM Franklin","year":"1997","unstructured":"Franklin GM, Checkoway H, Costa-Mallen P, Swanson PD, Smith-Weller T, Levy DG, Costa LG (1997) The \u201cprotective\u201d effect of smoking in Parkinson\u2019s disease is modified by an MAO-B polymorphism. Neurology 48:A334\u2013A335 (Abstract)","journal-title":"Neurology"},{"key":"9929_CR64","first-page":"265","volume":"35","author":"A Veral","year":"1997","unstructured":"Veral A, Alper G, Mentes G, Ersoz B (1997) Age and sex related alterations in serum and platelet monoamine oxidase. Eur J Clin Chem Clin Biochem 35:265\u2013268","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"9929_CR65","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410330406","volume":"33","author":"JH Kurth","year":"1993","unstructured":"Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD (1993) Association of monoamine oxidase-B allele with Parkinson\u2019s disease. Ann Neurol 33:368\u2013372. doi: 10.1002\/ana.410330406","journal-title":"Ann Neurol"},{"key":"9929_CR66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1096-8628(19970418)74:2<154::AID-AJMG7>3.0.CO;2-U","volume":"74","author":"P Costa","year":"1997","unstructured":"Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG (1997) Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 74:154\u2013156. doi: 10.1002\/(SICI)1096-8628(19970418)74:2<154::AID-AJMG7>3.0.CO;2-U","journal-title":"Am J Med Genet"},{"issue":"4","key":"9929_CR67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.parkreldis.2006.10.006","volume":"13","author":"M Bialecka","year":"2007","unstructured":"Bialecka M, Klodowska-Duda G, Honczarenko K, Gawronska-Szklarz B, Opala G, Safrano K, Drozdzik M (2007) Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), n-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson\u2019s disease. Parkinsonism Relat Disord 13(4):224\u2013229. doi: 10.1016\/j.parkreldis.2006.10.006","journal-title":"Parkinsonism Relat Disord"},{"key":"9929_CR68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s007020070075","volume":"107","author":"H Garpenstrand","year":"2000","unstructured":"Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L (2000) Platelet monoamine oxidase activity is related to MAO-B intron 13 genotype. J Neural Transm 107:523\u2013530. doi: 10.1007\/s007020070075","journal-title":"J Neural Transm"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-009-9929-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-009-9929-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-009-9929-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T23:42:13Z","timestamp":1738971733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-009-9929-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,4]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1007\/s11064-009-9929-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,4]]}}}